WO2011044568A1 - Crème topique pour la peau - Google Patents

Crème topique pour la peau Download PDF

Info

Publication number
WO2011044568A1
WO2011044568A1 PCT/US2010/052256 US2010052256W WO2011044568A1 WO 2011044568 A1 WO2011044568 A1 WO 2011044568A1 US 2010052256 W US2010052256 W US 2010052256W WO 2011044568 A1 WO2011044568 A1 WO 2011044568A1
Authority
WO
WIPO (PCT)
Prior art keywords
mixture
skin cream
producing
topical skin
container
Prior art date
Application number
PCT/US2010/052256
Other languages
English (en)
Inventor
Mizell Ligon William
Original Assignee
Mizell Ligon William
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mizell Ligon William filed Critical Mizell Ligon William
Publication of WO2011044568A1 publication Critical patent/WO2011044568A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Definitions

  • the present invention relates generally to lotions and creams for the skin, and more particularly to an improved topical skin cream that may be used to beautify and improve the overall appearance of the skin, to cleanse the skin, and to treat and relieve the symptoms of a variety of skin conditions, including tinea versicolor, atopic dermatitis (eczema), plaque psoriasis, athlete's foot, rashes, chemical and industrial related itching, acne, and similar conditions.
  • an improved topical skin cream may be used to beautify and improve the overall appearance of the skin, to cleanse the skin, and to treat and relieve the symptoms of a variety of skin conditions, including tinea versicolor, atopic dermatitis (eczema), plaque psoriasis, athlete's foot, rashes, chemical and industrial related itching, acne, and similar conditions.
  • United States Patent 5,322,685 to Nakagawa, et al. discloses a skin cream preparation for external use useful as a remedy for skin diseases which consists of a cream base comprising a diglycerol fatty acid ester and/or a sorbitan fatty acid ester having an HLB value of from 3 to 7, a polyvalent metal salt of a saturated or unsaturated fatty acid having 10 to 22 carbon atoms, an inorganic or organic acid salt, an oily phase component, and water together with an active ingredient.
  • United States Patent 6,348,199 to Vernice, et al. describes a clear, transparent highly stable skin moisturizing and lubricating composition obtained by combining polyglyceryl methacrylate with a pharmaceutically acceptable silicone, in the presence of a suitable emulsifier under application of pressure in the range of about 13,000 to about 50,000 psi.
  • the compositions are adapted for use as cosmetics and/or carriers for active drugs and serve in this form for treatment of skin irritations, burns, skin infections and the like.
  • a method of preparing the compositions of the invention is disclosed.
  • the invention also contemplates methods for lubricating and moisture replenishment of the skin, treating burns, skin infections and the like by topically applying the disclosed skin treatment compositions of the invention.
  • compositions for skin care are identical in lipid constituents and structural properties to that of human stratum corneum. They comprise the major constituents for the lipid lamellar of the stratum corneum, including ceramides, cholesterol and fatty acids, the major constituents for epidermal cell membranes, including phospholipids, and physiologically active substances, including phytosphingosine and its derivatives. Without causing side effects, the cream composition for skin care is of much better skin penetration and water-retention capacity than are conventional compositions comprised of ceramide and other components in forms different from those of human skin.
  • the cream composition brings about an improvement in the wrinkle condition of the skin, so that it can be applied to cosmetics. Also, it can be used as a medicinal material for the therapeutic treatment of inflammation, such as thermic erythema caused by IR and/or UV light.
  • United States Patent 6,932,976 to Brooks discloses an enzyme blocking skin protectant cream.
  • the skin protectant cream can be topically applied to protect skin from irritants, to block the action of irritants such as enzymes, and to treat skin that has been subject to irritants.
  • the cream can be applied manually or incorporated into disposable applicators, such as wipers or swabs.
  • the skin protectant cream is particularly useful in the prevention of severe skin breakdown which can lead to partial thickness skin wounds.
  • United States Patent 7,368,122 to Dow, et al. describes an emulsion for topical application to the skin containing a high molecular weight emulsifier and substantially no emulsifiers of a molecular weight less than 100 kD.
  • the emulsion may be used to prevent or treat dermatoses and may additionally contain pharmaceutically active ingredients.
  • United States Patent 7,557,094 to Wadstein teaches a skin cream composition containing chitosan conjugated CLA (conjugated linoleic acid) and a chitosan conjugated Vitamin A or a .beta.-cyclodextrin conjugated vitamin A.
  • the invention also concerns the preparation of the compositions.
  • the compositions according to the invention can be used as topical and cosmetic compositions as well as pharmaceutical compositions for treatment of atopical dermatitis, psoriasis eczema as well as eczema of different origins and solar dermatitis.
  • the present invention provides a topical skin cream comprising a mixture of sublimed sulfur powder, petroleum jelly (petrolatum, also known as soft paraffin), and baby oil (mineral oil), that may be used to beautify and improve the overall appearance of the skin, to cleanse the skin, and as a pharmaceutical to treat and relieve the symptoms of a variety of skin conditions.
  • the inventive skin cream can be applied and left on overnight as recommended or can be used as a mask and washed off 15 to 20 minutes after the initial topical application. When used as directed, a visible difference may be observed in as little as two days. The overall color and texture of the skin to a more natural and balanced look may be observed within 7 to 8 days.
  • the method for producing the inventive topical skin cream preferably includes the steps of providing a quantity of petroleum jelly into a first container and heating until liquefaction; providing a quantity of Sublimed Sulfur Powder in a second container; transferring at least some of the liquefied petroleum jelly from the first container into the second container; stirring the mixture with a utensil to a paste-like consistency; adding a quantity of baby oil into the second container; stirring the mixture with a utensil to a cream-like consistency; allowing the mixture to settle; and packaging the mixture for use.
  • inventive skin cream may be produced as a pharmaceutical and has been successfully used to treat and relieve the symptoms of a variety of skin conditions, including but not limited to the following:
  • Tinea Versicolor is a fungal skin infection characterized by dry, flaky, itchy spots that are lighter/darker than the surrounding pigment. When the temperature and humidity are high the fungi grows rapidly and the normal pigment of your skin changes and spots appear. These spots form clusters of discolored pigments on the face, chest, upper body, back and upper legs.
  • Atopic Dermatitis also called eczema or atopic eczema is characterized by superficial skin inflammation and intense itching. This disorder is associated with dry skin. Heat and humidity as well as stress may trigger eczema. The exact cause of eczema is unknown.
  • Athlete's Foot is a skin infection of the foot caused by a fungus called Trichophyton. This fungus can thrive and infect the upper layer of skin. This infection can occur anywhere including the scalp, arms, legs, nails, groins and other areas of the body.
  • Mild Plaque Psoriasis is the most common type of psoriasis. The skin is red and covered with silvery scales and is inflamed, itch and burns. These plaque patches are usually found on the arms, legs, scalp or any part of the body. Psoriasis is not contagious and can be inherited.
  • Rash / Chemical Itch may be evidenced by a scaly patch of skin not caused by an infection but may be produced by fungal or bacterial infection as well as scabies. Intense itching that is aggravated by scratching develops from employment that handles any chemicals that is absorbed thru the skin. This itching can cause many sleepless nights.
  • Ichthyosis is a genetic skin disorder that has dry, thickened, scaly or flaky skin that resemble the scales of fish. The severity varies from the mildest type which may be mistaken for normal dry skin up to life threatening conditions such as harlequin type ichthyosis.
  • a further object or feature of the present invention is a new and improved skin cream that may be used to cleanse the skin.
  • An even further object of the present invention is to provide a novel skin cream that may be used as a pharmaceutical to treat and relieve the symptoms of a variety of skin conditions.
  • All containers and mixing utensils that come into contact with or are used for mixing the materials for the inventive composition including, but not limited to: Sublimed Sulfur Powder, Petrolatum (petroleum jelly), and Baby Oil (mineral oil), are preferably non-metallic and/or have entirely non-metallic contact surfaces.
  • Sublimed Sulfur Powder, Petrolatum (petroleum jelly), and Baby Oil (mineral oil) are preferably non-metallic and/or have entirely non-metallic contact surfaces.
  • only wood, plastic, or glass containers and utensils are preferably used in any and all processes that contact and produce the inventive topical skin cream.
  • environmental and safety compatibility should be required so as to ensure there are no chemicals or substances given off from the container or surface into the mixture or product during the heating processes of production that may be harmful to human application.
  • Containers of other materials can be substituted for glass containers if similarly compatible.
  • Additional alternative mixing containers and utensils include ceramic, any type of natural stone including but not limited to granite, marble, quartz, and the like.
  • the inventive composition may also be able to be produced in any alternative container material with any alternative utensil material including stainless steel, aluminum, copper, or any other metal.
  • the composition ratio for the above-described composition intended for primary body application is 4 parts sublimed sulfur powder, 2 parts liquefied petroleum jelly, and 1 part baby oil (4:2: 1).
  • the composition ratio is preferably 8 parts sublimed sulfur powder, 4 parts liquefied petroleum jelly, and 1 part baby oil (8:4: 1).
  • the composition ratio is preferably 5 parts sublimed sulfur powder, 3 parts liquefied petroleum jelly, and 1 part baby oil (5:3: 1).
  • the composition ratio is preferably 3 1/3 parts sublimed sulfur powder, 2 parts liquefied petroleum jelly, and 1 part baby oil (3 1/3:2: 1).
  • the composition ratio is preferably 6 parts sublimed sulfur powder, 3 parts solid petroleum jelly, and 1 part baby oil (6:3: 1).
  • the above embodiments of the inventive composition comprise approximately 53-62% sublimed sulfur powder, 29-33% petroleum jelly, and 8-16% baby oil. These ratios and percentages may be adjusted as appropriate for different applications, for example, from 25-90%) sublimed sulfur powder, 15-50%) petroleum jelly, and 4- 25% baby oil. In all cases, the production process is preferably the same.
  • ingredients that may be used in the production of the inventive topical skin cream include, but are not limited to, the following: Absolute alcohol, Absorbase, Acid Mantle, Aloe Vera juice, Aloe Vera gel, Aluminum sulfate, Aquabase,

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition de crème topique pour la peau et un procédé pour sa fabrication, la composition comportant un mélange de poudre de souffre sublimé, de gelée de pétrole (petrolatum), et d'huile pour bébés (huile minérale), qui peut être utilisée pour embellir et améliorer l'aspect global de la peau, nettoyer la peau, et en tant qu'agent pharmaceutique, pour traiter et soulager les symptômes d'une diversité d'états de la peau.
PCT/US2010/052256 2009-10-09 2010-10-12 Crème topique pour la peau WO2011044568A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US27859409P 2009-10-09 2009-10-09
US61/278,594 2009-10-09
US33559910P 2010-01-11 2010-01-11
US61/335,599 2010-01-11
US35055610P 2010-06-02 2010-06-02
US61/350,556 2010-06-02

Publications (1)

Publication Number Publication Date
WO2011044568A1 true WO2011044568A1 (fr) 2011-04-14

Family

ID=43857186

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/052256 WO2011044568A1 (fr) 2009-10-09 2010-10-12 Crème topique pour la peau

Country Status (1)

Country Link
WO (1) WO2011044568A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3175888A1 (fr) * 2015-12-02 2017-06-07 Johnson & Johnson Consumer Inc. Compositions contenant du soufre polymérique et leurs utilisations

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192866A (en) * 1978-10-10 1980-03-11 Ralph Anderson Anorectal medication
US5997892A (en) * 1997-10-09 1999-12-07 Camp; Gary Don Topical therapeutic composition for and method of treating psoriasis
US20050064047A1 (en) * 2003-09-24 2005-03-24 Brian Penick Composition and method for treating skin disorders
US20060142587A1 (en) * 2004-11-08 2006-06-29 L'oreal Benzoisothiazolone compositions
US20060188459A1 (en) * 2005-02-22 2006-08-24 Franz-Leo Heinrichs Cosmetic, pharmaceutical or dermatological preparations comprising copolymer waxes
US20070154402A1 (en) * 2005-10-24 2007-07-05 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
US20090155383A1 (en) * 2007-10-26 2009-06-18 David Johnathan Kitko Personal Care Compositions Comprising Undecyl Sulfates
WO2009084032A2 (fr) * 2007-12-03 2009-07-09 Vedic Elements Private Limited Formulation topique hydrophobe stable à base de plantes

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192866A (en) * 1978-10-10 1980-03-11 Ralph Anderson Anorectal medication
US5997892A (en) * 1997-10-09 1999-12-07 Camp; Gary Don Topical therapeutic composition for and method of treating psoriasis
US20050064047A1 (en) * 2003-09-24 2005-03-24 Brian Penick Composition and method for treating skin disorders
US20060142587A1 (en) * 2004-11-08 2006-06-29 L'oreal Benzoisothiazolone compositions
US20060188459A1 (en) * 2005-02-22 2006-08-24 Franz-Leo Heinrichs Cosmetic, pharmaceutical or dermatological preparations comprising copolymer waxes
US20070154402A1 (en) * 2005-10-24 2007-07-05 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
US20090155383A1 (en) * 2007-10-26 2009-06-18 David Johnathan Kitko Personal Care Compositions Comprising Undecyl Sulfates
WO2009084032A2 (fr) * 2007-12-03 2009-07-09 Vedic Elements Private Limited Formulation topique hydrophobe stable à base de plantes

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3175888A1 (fr) * 2015-12-02 2017-06-07 Johnson & Johnson Consumer Inc. Compositions contenant du soufre polymérique et leurs utilisations
US10238685B2 (en) 2015-12-02 2019-03-26 Johnson & Johnson Consumer Inc. Compositions containing polymeric sulfur and uses thereof
AU2016266017B2 (en) * 2015-12-02 2022-09-29 Johnson & Johnson Consumer Inc. Compositions containing polymeric sulfur and uses thereof

Similar Documents

Publication Publication Date Title
WO2013067185A1 (fr) Formulation probiotique en bâtonnet pour l'entretien de la peau et ses procédés d'utilisation
TW200526260A (en) Cosmetic composition and methods
JP4612180B2 (ja) 皮膚外用剤
JP2007045776A (ja) 保湿剤及びこれを含有する化粧料及び皮膚外用剤
JP2009155227A (ja) 生体組織修復促進薬剤
US20230099298A1 (en) Cosmetic mask for application to the skin, and method for applying same
JPWO2007135841A1 (ja) ダイマージリノール酸ジエチレングリコールオリゴマーエステル含有化粧料
Eberting et al. Repairing a compromised skin barrier in dermatitis: leveraging the skin’s ability to heal itself
KR101460777B1 (ko) 여드름 개선용 화장료 조성물
JP3881411B2 (ja) 外用に適する組成物
JP2009161564A (ja) アトピー性皮膚炎治療用組成物
WO2011044568A1 (fr) Crème topique pour la peau
JP3507635B2 (ja) 外用に適する組成物
JP6001840B2 (ja) 生体組織用薬剤
WO2008091161A1 (fr) Composition cosmétique contenant de la spermine et de l'huile d'émeu
JP2003104886A (ja) 皮膚外用剤組成物
JP6664883B2 (ja) 外用組成物
JP2003342179A (ja) 老化防止剤
JP5171752B2 (ja) 皮膚外用剤
CN105106036A (zh) 活细胞丝肽护发素
CN110755349A (zh) 一种蒜素焕耀素颜霜及其制备方法
KR101814538B1 (ko) 바이오셀룰로오스의 분말을 유효성분으로 함유하는 셀룰라이트 감소 및 예방용 화장료 조성물
KR101814537B1 (ko) 바이오셀룰로오스의 분말을 유효성분으로 함유하는 셀룰라이트 감소 및 예방용 피부외용 조성물
WO2015015815A1 (fr) Activateur des fibroblastes
RU2715231C1 (ru) Косметическая маска-пленка для ухода за кожей лица с витаминами в липосомах

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10822828

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 10822828

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE